Axsome Therapeutics : AXS-12 SYMPHONY Results - Slides -March 25, 2024 at 08:33 am EDT
Topline data March 25, 2024 Forward Looking Statements & Safe Harbor Certain information contained in this...
Stay updated with breaking news from Clinical Global. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Topline data March 25, 2024 Forward Looking Statements & Safe Harbor Certain information contained in this...
02.01.2024 - Anavex Announces Topline Results from Phase 2/3 EXCELLENCE Clinical Study in Pediatric Rett Syndrome Validation from Real World Evidence (RWE) of Rett Syndrome Patients under Compassionate Use Authorization NEW YORK, Jan. 02, 2024 (GLOBE ... Seite 1
14.11.2022 - Enrollment continues in RECONNECT, a confirmatory pivotal Phase 3 trial of Zygel in patients with Fragile X syndrome (FXS); topline results expected second-half 2023 $55.9 million in cash and cash equivalents at September 30, 2022; Cash runway into ...